Where Travere Therapeutics Stands With Analysts
Where Travere Therapeutics Stands With Analysts
分析师如何评价Travere Therapeutics
The standing of Travere Therapeutics among financial experts becomes clear with...Travere Therapeutics (NASDAQ:TVTX) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Travere Therapeutics（纳斯达克:TVTX）在上个季度接受了14位分析师的分析，展现出了从看好到看淡的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $19.79, with a high estimate of $25.00 and a low estimate of $12.00. This current average reflects an increase of 11.37% from the previous average price target of $17.77.
分析师对12个月价格目标的评估提供了额外的见解，展示了平均目标为$19.79，高估为$25.00，低估为$12.00。当前的平均值反映了相比之前的平均目标价$17.77的上涨幅度为11.37%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
The standing of Travere Therapeutics among financial experts becomes clear with...
通过对最近的分析师行动...
登录免费看全文
登录/注册
资讯热榜
更新时间